+44 (0) 1223 755950
+1 832 327 7413
Beta-Catenin-Like Protein 1 (CTNNBL1) Antibody
REQUEST MORE INFO
Catalogue No: abx005043
Price:
US$348.00
(Size: 60 µl)
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
CTNNBL1 Antibody is a Rabbit Polyclonal antibody against CTNNBL1. The protein encoded by this gene is a component of the pre-mRNA-processing factor 19-cell division cycle 5-like (PRP19-CDC5L) protein complex, which activates pre-mRNA splicing and is an integral part of the spliceosome. The encoded protein is also a nuclear localization sequence binding protein, and binds to activation-induced deaminase and is important for antibody diversification. This gene may also be associated with the development of obesity. Alternative splicing results in multiple transcript variants. A pseudogene of this gene has been defined on the X chromosome.
Research Articles on Beta-Catenin-Like Protein 1 (CTNNBL1)
| Target | Beta-Catenin-Like Protein 1 (CTNNBL1) |
| Clonality | Polyclonal |
| Reactivity | Human, Mouse, Rat |
| Tested Applications | IF/ICC |
| Host | Rabbit |
| Recommended dilutions | IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein corresponding to human CTNNBL1 |
| Isotype | IgG |
| Form | Liquid |
| Purification | Purified by affinity chromatography. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| UniProt Primary AC | Q8WYA6 (UniProt, ExPASy) |
| UniProt Entry Name | CTBL1_HUMAN |
| Gene Symbol | CTNNBL1 |
| GeneID | 56259 |
| NCBI Accession | NP_110517.2 |
| KEGG | hsa:56259 |
| String | 9606.ENSP00000355050 |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol. |
| Concentration | 1 mg/ml |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |